FORTRESS BIOTECH, INC. sold 1.6% of their position (100K shares) of CHECKPOINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $129.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/3/2025ACC: 0001415889-25-015470
10% Owner
Since Jan 2023
-6.92M
Net shares
Net seller
$25.23M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.92M disposed
Non-Derivative Transactions2
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
−100K
Price / share
$1.29
Trade value
$129K
% of position
1.6%
5/29/2025
6.22M→6.12M
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
−6.12M
Price / share
$4.10
Trade value
$25.10M
% of position
New position
5/30/2025
6.12M→0.00
Total
Net shares
−6.22M
Net value
-$25.23M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 5/29/2025 | S · Sale | −100K | $1.29 | $129K | 1.6% | 6.22M | 6.12M |
| COMMON STOCK, PAR VALUE $0.0001 Direct | 5/30/2025 | D · Disposition | −6.12M | $4.10 | $25.10M | New position | 6.12M | 0.00 |
| Total | −6.22M | -$25.23M | ||||||
Derivative Transactions1
CLASS A COMMON STOCK, PAR VALUE $0.0001
Direct
Converts to
Common Stock
700K shares
Shares
−700K
Strike price
4.10
Held after
0.00
Exercisable
—
5/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| CLASS A COMMON STOCK, PAR VALUE $0.0001 Direct | Common Stock700K shares | 5/30/2025 | D · Disposition | −700K | 4.10 | — | 0.00 |